Showing results (141-150 of 467) with videos related to
Sort By:
Pageof 47
Pacing and Clinical Electrophysiology : PACE|August 13, 2004
Pacemaker diagnostics to determine treatment and outcome in sick sinus syndrome with paroxysmal atrial fibrillationAndrew J Marshall, Antony Nash, Paul A R Owen, et al.Australia and New Zealand Health Policy|April 21, 2005
Routine measurement of outcomes in Australia's public sector mental health servicesJane Pirkis, Philip Burgess, Tim Coombs, et al.Journal of Patient-Reported Outcomes|January 16, 2019
Development and adaptation of patient-reported outcome measures for patients who experience itch associated with primary biliary cholangitisMona L Martin, Larissa Stassek, Steven I Blum, et al.Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|November 17, 2006
Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological diseaseBruce V Taylor, Jan Williamson, David Jones, et al.Drugs - Real World Outcomes|September 21, 2023
Treatment Patterns by Race and Ethnicity in Newly Diagnosed Persons with Multiple SclerosisCaroline Kelley Geiger, Daniel Sheinson, Tu My To, et al.Neurology and Therapy|July 17, 2023
Real-World Clinical and Economic Outcomes Among Persons With Multiple Sclerosis Initiating First- Versus Second- or Later-Line Treatment With OcrelizumabCaroline K Geiger, Danny Sheinson, Tu My To, et al.Medicine, Science, and the Law|January 1, 2015
Development of a computational biomechanical infant model for the investigation of infant head injury by shakingMichael David Jones, Philip S Martin, Jonathan M Williams, et al.Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|March 3, 2009
Colorectal cancer patients' attitudes towards involvement in decision makingKinta Beaver, Malcolm Campbell, Olive Craven, et al.Quality & Safety in Health Care|October 5, 2007
Primary healthcare teams' views on using mortality data to review clinical policiesEmma Sullivan, Richard Baker, David Jones, et al.Liver International : Official Journal of the International Association for the Study of the Liver|May 15, 2023
Setanaxib, a first-in-class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo-controlled, phase 2 trialPietro Invernizzi, Marco Carbone, David Jones, et al.Pageof 47